Analyst Ratings for Roche (RHHBY)
RHHBY Rating Summary
RHHBY Price Target Summary
- Highest: $63.00 (Morgan Stanley)
- Lowest: $55.00 (Argus)
- Average: $59.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$59.00 (+7.3%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Avg. $ Target:
$59.00 (+7.3%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Morgan Stanley | Sarita Kapila | Upgrade | Overweight (Equalweight) |
63.00 (46.00) |
56.41 (54.97) |
-2.55% | Details |
| 4/6/2026 | Argus | Jasper Hellweg | Upgrade | Buy (Hold) |
55.00 (N/A) |
49.85 (54.97) |
10.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
